Sat, Dec 20, 2014, 3:10 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • waheed_jaqueed waheed_jaqueed Aug 3, 2013 3:54 PM Flag

    sgen vs imgn

    Interesting topic to think upon this weekend. 2 biotechs using similar technology to reach a similar goal with 2 different business plans.

    Sgen wants to make as many partners as it can using the high volume low return business model.
    Imgn wants to bring drugs to market and keep all the proceeds without using a partner to share the profits.

    One corporation will reap the short term rewards with lower risk due to the shear number of compounds in the pipeline.

    The other company will take on more risks in order to seek a larger long term payoff.

    It seems like Imgn hopes to become a biotech powerhouse to me but the payoff will need for their first wholly owned drug to be approved and brought to market. Kadcyla was always their giveaway as a means to an end. Kadcyla belongs to Roche and imgn has no control or even input on how it is marketed.

    Sentiment: Buy

 
IMGN
6.11-4.740(-43.69%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
3M Company
NYSEFri, Dec 19, 2014 4:04 PM EST
ImmunoGen, Inc.
NASDAQFri, Dec 19, 2014 4:00 PM EST
Southwestern Energy Co.
NYSEFri, Dec 19, 2014 4:05 PM EST